|
 |

|
Erika Bullesbach, Ph.D.
Associate Professor |
| |
|
|
| |
|
Ph.D.,
Rhinish-Westphalian Polytechnical University (Aachen) |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|

Office: 843-792-9926
Lab: 843-792-9930
Fax: 843-792-4850
Email: bullesee@musc.edu
BSB-740 |
|
| |
|
| |
Research Interests |
| |
The research interest of my
laboratory is the structure and function relationship of
insulin and factors of insulin-like structures. Structurally
related proteo-hormones of the insulin family are the
metabolic hormone insulin, the hormone of pregnancy relaxin,
the testicular Leydig cell derived relaxin-like factor, and
invertebrate developmental factors bombyxin (from the brains
of the silk worm) and the molluscan insulin-related peptide
(from neuroendocrine system of the pond snail). There is no
known biological crossreactivity between these insulin-like
hormones. The wide variety of biological functions inherent in
essentially the same three-dimensional structure implies that
the biological function of this family of proteins depends
primarily on the side chain distribution. It is the goal
to find the surface features that are crucial for the
corresponding hormone and its interaction with its cell
membrane receptor. The initial step of this investigation
involves the chemical synthesis of these factors and of
defined analogs. The syntheses are based upon a novel
approach, the site directed disulfide-bond formation, which
has been highly successful in the synthesis of insulin,
relaxins, relaxin-like factor, and bombyxin. Investigation of
the physical chemical and biological properties of the analogs
by comparison with natural factors will give insight into
their structure-function relationships. The long-term
goal of these studies is that a better understanding of the
mode of action of these hormones leads to the subsequent
design and synthesis of mimetics. Mimetics of insulins could
substitute for the daily injections of insulin-dependent
diabetes, and mimetics of bombyxin may become the basis of new
pest controls. |
|
| |
Selected Publications |
| |
- Büllesbach, E.E. and
Schwabe, C. (2001)
Synthesis and conformational analysis of the insulin-like 4
gene product. J. Pept. Res., 57(1): 77-83.
- Büllesbach, E.E. and
Schwabe, C. (2000)
The relaxin receptor-binding site geometry suggests a novel
gripping mode of interaction. J. Biol. Chem.,
275(45): 35276-35280.
- Fullbright, G. and
Büllesbach, E.E. (2000)
The receptor binding conformation of bombyxin is induced by
alanine (B15). Biochemistry, 39(32): 9718-9724.
- Lundquist, J.T. 4th,
Büllesbach, E.E. and Dix, T.A. (2000)
Synthesis of neurotensin (9-13) analogues exhibiting
enhanced human neurotensin receptor binding affinities.
Bioorg. Med. Chem. Lett., 10(5): 453-455.
- Büllesbach, E.E.,
Rhodes, R., Rembiesa, B. and Schwabe, C. (1999)
The relaxin-like factor is a hormone. Endocrine,
10(2): 167-169.
- Büllesbach, E.E.
(1999)
Bombyxin exhibits an insulin-like response to modification
in the N-terminal region of the A chain. J. Pept.
Res., 54(1): 12-17.
- Büllesbach, E.E. and
Schwabe, C. (1999)
Specific, high affinity relaxin-like factor receptors.
J. Biol. Chem., 274(32): 22354-22358.
- Büllesbach, E.E.,
and Schwabe, C. (1999)
Tryptophan B27 in the relaxin-like factor (RLF) is crucial
for RLF receptor binding. Biochemistry
38 (10): 3073-3078.
- Fullbright, G., Lacy, E.R.,
and Büllesbach, E.E. (1997)
The prothoracicotropic hormone bombyxin has specific
receptors on insect ovarian cells.
Eur. J. Biochem. 245: 774-780.
- Büllesbach, E.E.,
Steinetz, B.G., and Schwabe, C. (1996)
Chemical synthesis of a Zwitterhormon, insulaxin, and of a
relaxin-like bombyxin derivative. Biochemistry
35: 9754-9760.
- Büllesbach, E.E. and
Schwabe, C. (1995)
A novel Leydig cell cDNA-derived protein is a relaxin-like
factor (RLF). J. Biol. Chem. 370: 16011-16015
- Büllesbach, E.E.,
Yang, S. and Schwabe, C. (1992)
The receptor-binding site of human relaxin II: A dual
prong-binding mechanism. J. Biol. Chem. 267:
22957-22960.
- Büllesbach, E.E. and
Schwabe, C. (1991)
Total synthesis of human relaxin and human relaxin
derivatives by solid phase peptide synthesis and site
directed chain combination. J. Biol. Chem. 266:
10754-10761.
|
|
|
| |
|
|